Clinical trial
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00004186 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00004186 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer |
| Official title | Phase I/IIA Study of Sequential Ifosfamide and Topotecan in Patients With Small Cell Lung Cancer |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, etoposide, ifosfamide, topotecan hydrochloride, radiation therapy |
| Enrollment | 55 |
| Start date | Dec 1, 1996 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Aug 5, 2004 |
| Last update posted | Apr 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: